Research Article
Cyclin D1 Expression and Its Correlation with Histopathological Differentiation in Oral Squamous Cell Carcinoma
Table 1
Distribution of site, clinical staging, histopathological differentiation of OSCC, and their IHC reactivity.
| Distribution category | Total number | IHC reactivity | Positive () | Negative () | % of positive reactivity | |
| Site | | | | |
0.282 NS | āAlveolus | 11 | 07 | 04 | 63.63 | āBuccal mucosa | 13 | 05 | 08 | 38.46 | āTongue | 15 | 05 | 10 | 33.33 | āLip | 01 | 01 | 00 | 100 |
| Clinical staging | | | | |
0.867 NS | āStage I | 06 | 03 | 03 | 50 | āStage II | 07 | 04 | 03 | 57.14 | āStage III | 13 | 05 | 08 | 38.4 | āStage IV | 14 | 06 | 08 | 42.8 |
| Histopathological differentiation | | | | | | āWDSCC | 13 | 09 | 04 | 69.23 |
0.011 S | āMDSCC | 16 | 08 | 08 | 50 | āPDSCC | 11 | 01 | 10 | 9.09 |
| OSCC (total) | 40 | 18 | 22 | 45 | |
|
|